A New Safe Harbor - Turning Drug Rebates into Discounts in Medicare Part D.

Gellad, Walid F; Ennis, Molly; Kuza, Courtney C

Gellad, Walid F; Ennis, Molly; Kuza, Courtney C.

Afiliação

Gellad WF; From the Division of General Internal Medicine, School of Medicine (W.F.G.), the Center for Pharmaceutical Policy and Prescribing (W.F.G., C.C.K.), and the Health Policy Institute, Schools of the Health Sciences (M.E.), University of Pittsburgh, and the Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System (W.F.G.) - all in Pittsburgh.
Ennis M; From the Division of General Internal Medicine, School of Medicine (W.F.G.), the Center for Pharmaceutical Policy and Prescribing (W.F.G., C.C.K.), and the Health Policy Institute, Schools of the Health Sciences (M.E.), University of Pittsburgh, and the Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System (W.F.G.) - all in Pittsburgh.
Kuza CC; From the Division of General Internal Medicine, School of Medicine (W.F.G.), the Center for Pharmaceutical Policy and Prescribing (W.F.G., C.C.K.), and the Health Policy Institute, Schools of the Health Sciences (M.E.), University of Pittsburgh, and the Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System (W.F.G.) - all in Pittsburgh.

N Engl J Med ; 380(18): 1688-1690, 2019 May 02.

Article em En | MEDLINE | ID: mdl-30946552

Assuntos

Custos de Medicamentos/legislação & jurisprudência; Indústria Farmacêutica/economia; Medicare Part D/economia; Medicamentos sob Prescrição/economia; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Indústria Farmacêutica / Medicare Part D / Medicamentos sob Prescrição País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google